Related Experiment Video
Updated: Jun 24, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
SARS-CoV-2-related Multisystem Inflammatory Syndrome in Children: A case series
Nawal Al Maskari1, Kholoud Al Mukhaini1, Safiya Al Abrawi1
1Department of Child Health, Royal Hospital, Muscat, Oman.
Insights
Multisystem inflammatory syndrome in children (MIS-C), a COVID-19 complication, presents with hyperinflammation. This study reports on six Omani children with MIS-C who fully recovered with supportive care and specific treatments.
Area of Science:
- Pediatrics
- Infectious Diseases
- Critical Care Medicine
Background:
- Emergence of a novel hyperinflammatory syndrome linked to COVID-19 in children.
- Multisystem Inflammatory Syndrome in Children (MIS-C) shares features with Kawasaki disease and toxic shock syndrome.
Observation:
- Six pediatric cases of MIS-C admitted to Omani hospitals (June-July 2020).
- Presentations varied, including need for pediatric intensive care unit support and appendicitis suspicion.
- Five patients were younger than the reported median age for MIS-C.
Findings:
- All six pediatric patients achieved complete recovery.
- Treatment involved supportive management, intravenous immunoglobulin, steroids.
- One patient required an interleukin-6 inhibitor (tocilizumab) for refractory symptoms.
Implications:
- Highlights the occurrence and clinical spectrum of MIS-C in Oman.
- Demonstrates the effectiveness of current treatment modalities for MIS-C.
- Suggests potential for MIS-C to affect younger children than previously documented.
Abstract:
On 27 April 2020, the National Health Service England issued an emergency alert for a new condition owing to the observation of an increasing number of cases of a COVID-19-related hyperinflammatory syndrome termed multisystem inflammatory syndrome in children (MIS-C). Some of the presenting symptoms appeared similar to the Kawasaki disease and toxic shock syndrome. We report the cases of six children fitting the criteria of MIS-C, admitted to Royal Hospital and Sohar Hospital, Oman, between the months of June and July in 2020. Four of these patients required admission at the paediatric intensive care unit for inotropic support while two were admitted to the paediatric ward on suspicion of appendicitis. MIS-C has been reported in a small number of individuals below the age of 21 years with a median age of 9-10 years. Five of the current patients were aged less than the median age reported in the existing literature. All of the patients showed complete recovery with supportive management, intravenous immunoglobulin and steroids, with one patient requiring interleukin-6 inhibitor (tocilizumab).
More Related Videos
07:50A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
08:44Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rocky Mountain Spotted Fever
Viral Meningitis
Cytomegalovirus Disease
Respiratory Syncytial Virus Disease